MecaBioTech Solutions: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MecaBioTech Solutions
Largest movements
- Cash +€38,272
up €38,272 (+38.2%), from €100,079 to €138,352
mainly Net result for the year (+€35,243) and Depreciation (+€15,271)
- Receivables within one year +€13,284
up €13,284 (+47.8%), from €27,785 to €41,069
of which Trade receivables: +€13,284
- Tangible fixed assets -€5,614
down €5,614 (-14.6%), from €38,544 to €32,930
of which Plant, machinery and equipment: -€3,988
- Reserves +€30,000
up €30,000 (+60.0%), from €50,000 to €80,000
- Tax, wage and social debts +€8,957
up €8,957 (+67.7%), from €13,225 to €22,182
- Profit (loss) carried forward +€5,243
up €5,243 (+6.1%), from €86,186 to €91,429
- Trade debts +€3,387
up €3,387 (+33.8%), from €10,035 to €13,422
- Other debts -€3,317
down €3,317 (-72.1%), from €4,602 to €1,285
- Gross operating margin -€6,993
down €6,993 (-9.3%), from €74,909 to €67,916
- Depreciation -€5,576
down €5,576 (-26.7%), from €20,846 to €15,271
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €169,047 | €213,318 | +€44,271 | +26.2% |
| Fixed assets | 21/28 | €38,544 | €32,930 | -€5,614 | -14.6% |
| Tangible fixed assets | 22/27 | €38,544 | €32,930 | -€5,614 | -14.6% |
| Plant, machinery and equipment | 23 | €24,236 | €20,248 | -€3,988 | -16.5% |
| Furniture and vehicles | 24 | €14,308 | €12,681 | -€1,626 | -11.4% |
| Current assets | 29/58 | €130,503 | €180,388 | +€49,885 | +38.2% |
| Amounts receivable within one year | 40/41 | €27,785 | €41,069 | +€13,284 | +47.8% |
| Trade receivables | 40 | €27,579 | €40,863 | +€13,284 | +48.2% |
| Other amounts receivable | 41 | €207 | €207 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €100,079 | €138,352 | +€38,272 | +38.2% |
| Deferred charges and accrued income | 490/1 | €2,639 | €967 | -€1,672 | -63.4% |
| Total equity and liabilities | 10/49 | €169,047 | €213,318 | +€44,271 | +26.2% |
| Equity | 10/15 | €141,186 | €176,429 | +€35,243 | +25.0% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €50,000 | €80,000 | +€30,000 | +60.0% |
| Distributable reserves | 133 | €50,000 | €80,000 | +€30,000 | +60.0% |
| Profit (loss) carried forward | 14 | €86,186 | €91,429 | +€5,243 | +6.1% |
| Amounts payable | 17/49 | €27,861 | €36,889 | +€9,027 | +32.4% |
| Amounts payable within one year | 42/48 | €27,861 | €36,889 | +€9,027 | +32.4% |
| Current portion of amounts payable after more than one year | 42 | €0 | - | = | |
| Trade debts | 44 | €10,035 | €13,422 | +€3,387 | +33.8% |
| Suppliers | 440/4 | €10,035 | €13,422 | +€3,387 | +33.8% |
| Taxes, remuneration and social security | 45 | €13,225 | €22,182 | +€8,957 | +67.7% |
| Taxes | 450/3 | €13,225 | €22,182 | +€8,957 | +67.7% |
| Other amounts payable | 47/48 | €4,602 | €1,285 | -€3,317 | -72.1% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €20,846 | €15,271 | -€5,576 | -26.7% |
| Other operating charges | 640/8 | €974 | €648 | -€326 | -33.5% |
| Gross operating margin | 9900 | €74,909 | €67,916 | -€6,993 | -9.3% |
| Operating profit (loss) | 9901 | €53,089 | €51,997 | -€1,092 | -2.1% |
| Financial income | 75/76B | €0 | €0 | -€0 | -100% |
| Recurring financial income | 75 | €0 | €0 | -€0 | -100% |
| Financial charges | 65/66B | €280 | €169 | -€111 | -39.7% |
| Recurring financial charges | 65 | €280 | €169 | -€111 | -39.7% |
| Profit (loss) for the period before taxes | 9903 | €52,809 | €51,828 | -€980 | -1.9% |
| Income taxes | 67/77 | €16,100 | €16,585 | +€485 | +3.0% |
| Profit (loss) for the period | 9904 | €36,709 | €35,243 | -€1,466 | -4.0% |
| Profit (loss) for the period to be appropriated | 9905 | €36,709 | €35,243 | -€1,466 | -4.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.